HANYANG ENG Co.,Ltd (KOSDAQ:045100)
South Korea
· Delayed Price · Currency is KRW 33,650
-1,300 (-3.72%)
At close: Apr 28, 2026
HANYANG ENG Co.,Ltd Revenue
In the year 2025, HANYANG ENG Co.,Ltd had annual revenue of 1.12T KRW, down -5.74%. HANYANG ENG Co.,Ltd had revenue of 307.41B in the quarter ending December 31, 2025, a decrease of -3.83%.
Revenue
1,118.18B
Revenue Growth
-5.74%
P/S Ratio
0.48
Revenue / Employee
1.06B
Employees
1,050
Market Cap
538.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,118.18B | -68.11B | -5.74% |
| Dec 31, 2024 | 1,186.29B | 160.13B | 15.60% |
| Dec 31, 2023 | 1,026.17B | -136.73B | -11.76% |
| Dec 31, 2022 | 1,162.89B | 271.86B | 30.51% |
| Dec 31, 2021 | 891.03B | 132.57B | 17.48% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dongwha Enterprise Co.,Ltd | 829.56B |
| STI Co., Ltd. | 328.06B |
| GnCenergy | 262.63B |
| Pum-Tech Korea | 371.96B |
| Worldex Industry & Trading | 291.76B |
| Hy-Lok | 214.57B |
| Synopex | 261.54B |
| ImmuneOncia Therapeutics | 111.21M |